⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1860691 | 0.63 | — | — | |
| SCHEMBL847951 | 0.61 | TSHR (0.34) | — | |
| SCHEMBL1588075 | 0.61 | TSHR (0.34) | — | |
| SCHEMBL847288 | 0.61 | TSHR (0.34) | — | |
| SCHEMBL9817562 | 0.61 | TSHR (0.34) | — | |
| SCHEMBL7408718 | 0.58 | — | — | |
| SCHEMBL4942823 | 0.58 | — | — | |
| SCHEMBL24982807 | 0.57 | — | — | |
| SCHEMBL10580861 | 0.57 | — | — | |
| SCHEMBL2320997 | 0.56 | ALDH1A1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7939509-B2 | Partial and full agonists of A1 adenosine receptors | GILEAD SCIENCES, INC. (US) | 2011-05-10 | — | — | US | disclosed |
| EP-2259790-A1 | ABCA-1 ELEVATING COMPOUNDS AND THE USE THEREOF | Gilead Palo Alto, Inc. (US) | 2010-12-15 | — | — | EP | disclosed |
| US-20100210579-A1 | PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS | GILEAD PALO ALTO, INC. (US) | 2010-08-19 | — | — | US | disclosed |
| US-7713946-B2 | Partial and full agonists A1 adenosine receptors | CV THERAPEUTICS, INC. (US) | 2010-05-11 | — | — | US | disclosed |
| US-7655638-B2 | 2-{6-[((1R,2R)-2-hydroxycyclopentyl)amino]purin-9-yl}(4S,5S,2R,3R)-5-[(2-chloro-6-methylphenylthio)methyl]oxolane-3,4-diol; atrial fibrillation, tachycardia and atrial flutter, congestive heart failure, epilepsy, stroke, diabetes, obesity, ischemia, angina, cardiac transplant, and myocardial infarction | GILEAD PALO ALTO, INC. (US) | 2010-02-02 | — | — | US | disclosed |
| EP-2120954-A1 | ADENOSINE DERIVATIVES AS PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS | CV Therapeutics Inc. (US) | 2009-11-25 | — | — | EP | disclosed |
| US-20090247557-A1 | PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS | GILEAD SCIENCES, INC. | 2009-10-01 | — | — | US | disclosed |
| WO-2009100326-A1 | ABCA-1 ELEVATING COMPOUNDS AND THE USE THEREOF | CV THERAPEUTICS, INC. (US) | 2009-08-13 | — | — | WO | disclosed |
| US-20090203689-A1 | ABCA-1 ELEVATING COMPOUNDS AND METHODS | CV THERAPEUTICS, INC. | 2009-08-13 | — | — | US | disclosed |
| WO-2008077050-A1 | ADENOSINE DERIVATIVES AS PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS | CV THERAPEUTICS, INC. (US) | 2008-06-26 | — | — | WO | disclosed |
| US-20070185051-A1 | Partial and full agonists of A1 adenosine receptors | GILEAD SCIENCES, INC. | 2007-08-09 | — | — | US | disclosed |
| US-20070066560-A1 | Partial and full agonists of A1 adenosine receptors | ELZEIN ELFATIH | 2007-03-22 | — | — | US | disclosed |
| US-7157440-B2 | Partial and full agonists of A1 adenosine receptors | CV THERAPEUTICS, INC. (US) | 2007-01-02 | — | — | US | disclosed |
| US-6946449-B2 | Partial and full agonists of A1 adenosine receptors | CV THERAPEUTICS, INC. (US) | 2005-09-20 | — | — | US | disclosed |
| US-20050020532-A1 | Partial and full agonists of A1 adenosine receptors | GILEAD PALO ALTO, INC. | 2005-01-27 | — | — | US | disclosed |
| WO-2004007519-A1 | PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS | CV THERAPEUTICS, INC. (US) | 2004-01-22 | — | — | WO | disclosed |
| US-20030050275-A1 | Partial and full agonists of A1 adenosine receptors | GILEAD PALO ALTO, INC. | 2003-03-13 | — | — | US | disclosed |